Henshaw Capital’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,618	Closed	-$660K	–	263
2025 Q3	$660K	Sell	27,618 -6,749	-20%	-$127K	0.02%	145
2025 Q2	$509K	Hold	34,367	–	–	0.02%	230
2025 Q1	$616K	Buy	34,367 +5,194	+18%	+$105K	0.03%	201
2024 Q4	$508K	Hold	29,173	–	–	0.02%	216
2024 Q3	$408K	Hold	29,173	–	–	0.02%	250
2024 Q2	$240K	Hold	29,173	–	–	0.01%	271
2024 Q1	$225K	Hold	29,173	–	–	0.01%	272
2023 Q4	$262K	Hold	29,173	–	–	0.01%	256
2023 Q3	$261K	Buy	29,173 +12,686	+77%	+$179K	0.02%	243
2023 Q2	$253K	Hold	16,487	–	–	0.01%	207
2023 Q1	$371K	Hold	16,487	–	–	0.02%	155
2022 Q4	$347K	Buy	16,487 +1,989	+14%	+$42.1K	0.02%	158
2022 Q3	$357K	Sell	14,498 -1,734	-11%	-$44.8K	0.03%	178
2022 Q2	$393K	Hold	16,232	–	–	0.03%	169
2022 Q1	$418K	Sell	16,232 -1,374	-8%	-$36.5K	0.02%	185
2021 Q4	$546K	Hold	17,606	–	–	0.03%	163
2021 Q3	$427K	Hold	17,606	–	–	0.03%	184
2021 Q2	$257K	Buy	17,606 +4,573	+35%	+$90.2K	0.02%	310
2021 Q1	$325K	Buy	13,033 +327	+3%	+$9.04K	0.02%	250
2020 Q4	$346K	Sell	12,706 -2,497	-16%	-$58.3K	0.03%	223
2020 Q3	$281K	Hold	15,203	–	–	0.02%	239
2020 Q2	$310K	Hold	15,203	–	–	0.03%	210
2020 Q1	$222K	Buy	+15,203	New	+$229K	0.02%	237
2019 Q2	–	Sell	-9,136	Closed	-$207K	–	305
2019 Q1	$207K	Buy	9,136 +182	+2%	+$4.02K	0.02%	268
2018 Q4	$203K	Buy	+8,954	New	+$223K	0.02%	253